2. GPCR/G Protein Neuronal Signaling
  3. mGluR
  4. 2055538-47-9

2055538-47-9

Cintirorgon sodium Chemical Structure

2055538-47-9

Chemical Structure

  • Cintirorgon sodium
  • Synonym(s): LYC-55716 sodium
  • CAS No: 2055538-47-9
    Formula: C27H22F6NNaO6S
    Molecular Weight: 625.51
  • IUPAC Name: sodium (S)-3-(6-(3-(difluoromethoxy)-5-fluorophenyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)-2,2-dimethylpropanoate
  • InChIKey: NWMACPZNQFABGF-BDQAORGHSA-M
  • SMILES: O=C(O[Na])C(C)(C)C[C@@H]1OC2=CC=C(C3=CC(F)=CC(OC(F)F)=C3)C=C2N(S(=O)(C4=CC=CC(C(F)(F)F)=C4)=O)C1

Biological Activity: Cintirorgon sodium is a first-in-class, selective and orally bioavailable RORγ agonist. Cintirorgon sodium (LYC-55716) modulates gene expression of RORγ expressing T lymphocyte immune cells, resulting in enhanced effector function, as well as decreased immunosuppression, resulting in decreased tumor growth, and improved survival[1][2].

Cat. No. Product Name Purity Description
HY-104037A Cintirorgon sodium Cintirorgon sodium is a first-in-class, selective and orally bioavailable RORγ agonist. Cintirorgon sodium (LYC-55716) modulates gene expression of RORγ expressing T lymphocyte immune cells, resulting in enhanced effector function, as well as decreased immunosuppression, resulting in decreased tumor growth, and improved survival.

References

[1]. Lycera Announces Initiation of Phase 1/2a Study ARGON of Immuno-Oncology Candidate LYC-55716 in Patients with Advanced Solid Tumors. Jan 04, 2017.

Keywords:

Cintirorgon sodium